A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease

FASEB Journal

Volumn 26, Issue 2, 2012, Pages 907-916

  Renner, Pascal ^a   Roger, Thierry ^a   Bochud, Pierre Yves ^a   Sprong, Tom ^c,d   Sweep, Fred C G J ^c   Bochud, Murielle ^b   Faust, Saul N ^e,f,g   Haralambous, Elene ^h   Betts, Helen ^h   Chanson, Anne Laure ^a   Reymond, Marlies Knaup ^a   Mermel, Elliot ^a   Erard, Veronique ^a   Van Deuren, Marcel ^c   Read, Robert C ^i,j   Levin, Michael ^h   Calandra, Thierry ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^g WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^j SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

Cytokine; Gene polymorphism; Neisseria meningitidis; Sepsis

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; ALLELE; ARTICLE; DEATH; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCEMIA; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; PROGENY;

ADOLESCENT; ALLELES; BASE SEQUENCE; CELL LINE; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; FEMALE; GREAT BRITAIN; HOMOZYGOTE; HUMANS; INFANT; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MICROSATELLITE REPEATS; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEPSIS;

NEISSERIA MENINGITIDIS;

EID: 84856528328     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-195065     Document Type: Article

References (79)

1. Bloom, B. R., and Bennett, B. (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80-82
2. David, J. R. (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. U. S. A. 56, 72-77
3. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., and Bucala, R. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-759 (Pubitemid 23339882)
4. Calandra, T., Bernhagen, J., Mitchell, R. A., and Bucala, R. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179, 1895-1902 (Pubitemid 24155670)
5. Calandra, T., and Roger, T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800 (Pubitemid 37328657)
6. Flaster, H., Bernhagen, J., Calandra, T., and Bucala, R. (2007) The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol. Endocrinol. 21, 1267-1280 (Pubitemid 46984737)
7. Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71
8. Bacher, M., Metz, C. N., Calandra, T., Mayer, K., Chesney, J., Lohofft, M., Gemsat, D., Donnelly, T., and Bucala, R. (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. U. S. A. 93, 7849-7854 (Pubitemid 26277127)
9. Calandra, T., Spiegel, L. A., Metz, C. N., and Bucala, R. (1998) Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria. Proc. Natl. Acad. Sci. U. S. A. 95, 11383-11388 (Pubitemid 28450137)
10. Rossi, A. G., Haslett, C., Hirani, N., Greening, A. P., Rahman, I., Metz, C. N., Bucala, R., and Donnelly, S. C. (1998) Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J. Clin. Invest. 101, 2869-2874 (Pubitemid 28294596)
11. Maxime, V., Fitting, C., Annane, D., and Cavaillon, J. M. (2005) Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock. J. Infect. Dis. 191, 138-144 (Pubitemid 40041412)
12. Bucala, R., and Donnelly, S. C. (2007) Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26, 281-285 (Pubitemid 46413914)
13. Leng, L., Metz, C. N., Fang, Y., Xu, Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., and Bucala, R. (2003) MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197, 1467-1476 (Pubitemid 36686708)
14. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., Kooistra, T., Fingerle-Rowson, G., Ghezzi, P., Kleemann, R., McColl, S. R., Bucala, R., Hickey, M. J., and Weber, C. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596 (Pubitemid 46828480)
15. Schwartz, V., Lue, H., Kraemer, S., Korbiel, J., Krohn, R., Ohl, K., Bucala, R., Weber, C., and Bernhagen, J. (2009) A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 583, 2749-2757
16. Mitchell, R. A., Metz, C. N., Peng, T., and Bucala, R. (1999) Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 274, 18100-18106
17. Santos, L. L., Lacey, D., Yang, Y., Leech, M., and Morand, E. F. (2004) Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor. J. Rheumatol. 31, 1038-1043 (Pubitemid 38715876)
18. Lue, H., Thiele, M., Franz, J., Dahl, E., Speckgens, S., Leng, L., Fingerle-Rowson, G., Bucala, R., Lüscher, B., and Bernhagen, J. (2007) Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5//JAB1 in the control of autocrine MIF activity. Oncogene 26, 5046-5059 (Pubitemid 47206949)
19. Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., and Beach, D. H. (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190, 1375-1382
20. Kleemann, R., Hausser, A., Geiger, G., Mischke, R., Burger-Kentischer, A., Flieger, O., Johannes, F.-J., Roger, T., Calandra, T., Kapurniotu, A., Grell, M., Finkelmeier, D., Brunner, H., and Bernhagen, J. (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408, 211-216
21. Filip, A. M., Klug, J., Cayli, S., Fröhlich, S., Henke, T., Lacher, P., Eickhoff, R., Bulau, P., Linder, M., Carlsson-Skwirut, C., Leng, L., Bucala, R., Kraemer, S., Bernhagen, J., and Meinhardt, A. (2009) Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function. J. Biol. Chem. 284, 7977-7985
22. Daun, J. M., and Cannon, J. G. (2000) Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. Am. J. Physiol. 279, R1043-R1049
23. Roger, T., Chanson, A. L., Knaup-Reymond, M., and Calandra, T. (2005) Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur. J. Immunol. 35, 3405-3413 (Pubitemid 43025521)
24. Aeberli, D., Yang, Y., Mansell, A., Santos, L., Leech, M., and Morand, E. F. (2006) Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett. 580, 974-981 (Pubitemid 43152322)
25. Greven, D., Leng, L., and Bucala, R. (2010) Autoimmune diseases: MIF as a therapeutic target. Expert Opin. Ther. Targets 14, 253-264
26. Bozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., Gerard, C., and David, J. R. (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189, 341-346 (Pubitemid 29063255)
27. Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hültner, L., Heumann, D., Männel, D., Bucala, R., and Glauser, M. P. (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6, 164-170 (Pubitemid 30082360)
28. Beishuizen, A., Thijs, L. G., Haanen, C., and Vermes, I. (2001) Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J. Clin. Endocrinol. Metab. 86, 2811-2816 (Pubitemid 32545744)
29. Gando, S., Nishihira, J., Kobayashi, S., Morimoto, Y., Nanzaki, S., and Kemmotsu, O. (2001) Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Med. 27, 1187-1193 (Pubitemid 32710206)
30. Lehmann, L. E., Novender, U., Schroeder, S., Pietsch, T., Spiegel, T. V., Putensen, C., Hoeft, A., and Stuber, F. (2001) Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med. 27, 1412-1415 (Pubitemid 32758941)
31. Bozza, F. A., Gomes, R. N., Japiassu, A. M., Soares, M., Castro-Faria-Neto, H. C., Bozza, P. T., and Bozza, M. T. (2004) Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 22, 309-313 (Pubitemid 39480698)
32. Emonts, M., Sweep, F. C. G. J., Grebenchtchikov, N., Geurts-Moespot, A., Knaup, M., Chanson, A. L., Erard, V., Renner, P., Hermans, P. W. M., Hazelzet, J. A., and Calandra, T. (2007) Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin. Infect. Dis. 44, 1321-1328 (Pubitemid 46717294)
33. Sprong, T., Pickkers, P., Geurts-Moespot, A., Van Der Ven-Jongekrijg, J., Neeleman, C., Knaup, M., Leroy, D., Calandra, T., Van Der Meer, J. W. M., Sweep, F., and Van Deuren, M. (2007) Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia. Shock 27, 482-487 (Pubitemid 46626074)
34. Baugh, J. A., Gantier, M., Li, L., Byrne, A., Buckley, A., and Donnelly, S. C. (2006) Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem. Biophys. Res. Commun. 347, 895-903 (Pubitemid 44118203)
35. Roger, T., Ding, X., Chanson, A. L., Renner, P., and Calandra, T. (2007) Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression. Eur. J. Immunol. 37, 3509-3521
36. Leng, L., Wang, W., Roger, T., Merk, M., Wuttke, M., Calandra, T., and Bucala, R. (2009) Glucocorticoid-induced MIF expression by human CEM T cells. Cytokine 48, 177-185
37. Veillat, V., Lavoie, C. H., Metz, C. N., Roger, T., Labelle, Y., and Akoum, A. (2009) Involvement of nuclear factor-kappaB in macrophage migration inhibitory factor gene transcription upregulation induced by interleukin-1 beta in ectopic endometrial cells. Fertil. Steril. 91, 2148-2156
38. Baugh, J. A., Chitnis, S., Donnelly, S. C., Monteiro, J., Lin, X., Plant, B. J., Wolfe, F., Gregersen, P. K., and Bucala, R. (2002) A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 3, 170-176 (Pubitemid 38961128)
39. Donn, R. P., Shelley, E., Ollier, W. E., and Thomson, W. (2001) A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 44, 1782-1785 (Pubitemid 32758224)
40. Gregersen, P. K., and Bucala, R. (2003) Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum. 48, 1171-1176 (Pubitemid 36554515)
41. Renner, P., Roger, T., and Calandra, T. (2005) Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin. Infect. Dis. 41(Suppl. 7), S513-S519 (Pubitemid 41598313)
42. Roger, T., David, J., Glauser, M. P., and Calandra, T. (2001) MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920-924 (Pubitemid 34024744)
43. Stephens, D. S., Greenwood, B., and Brandtzaeg, P. (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369, 2196-2210 (Pubitemid 46977462)
44. Virji, M. (2009) Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat. Rev. Microbiol. 7, 274-286
45. Kim, K. S. (2010) Acute bacterial meningitis in infants and children. Lancet Infect. Dis. 10, 32-42
46. Haralambous, E., Weiss, H. A., Radalowicz, A., Hibberd, M. L., Booy, R., and Levin, M. (2003) Sibling familial risk ratio of meningococcal disease in UK Caucasians. Epidemiol. Infect. 130, 413-418 (Pubitemid 36722779)
47. Emonts, M., Hazelzet, J. A., de Groot, R., and Hermans, P. W. (2003) Host genetic determinants of Neisseria meningitidis infections. Lancet Infect. Dis. 3, 565-577 (Pubitemid 37064536)
48. Brouwer, M. C., de Gans, J., Heckenberg, S. G., Zwinderman, A. H., van der Poll, T., and van de Beek, D. (2009) Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis. 9, 31-44
49. Davila, S., Wright, V. J., Khor, C. C., Sim, K. S., Binder, A., Breunis, W. B., Inwald, D., Nadel, S., Betts, H., Carrol, E. D., de Groot, R., Hermans, P. W. M., Hazelzet, J., Emonts, M., Lim, C. C., Kuijpers, T. W., Martinon-Torres, F., Salas, A., Zenz, W., Levin, M., and Hibberd, M. L., for the International Meningococcal Genetics Consortium (2010) Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat. Genet. 42, 772-776
50. Wright, V., Hibberd, M., and Levin, M. (2009) Genetic polymorphisms in host response to meningococcal infection: the role of susceptibility and severity genes. Vaccine 27(Suppl. 2), B90-102
51. Smirnova, I., Mann, N., Dols, A., Derkx, H. H. Hibberd, M. L., Levin, M., and Beutler, B. (2003) Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl. Acad. Sci. U. S. A. 100, 6075-6080 (Pubitemid 36576933)
52. Slater, A., Shann, F., and Pearson, G. (2003) PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med. 29, 278-285 (Pubitemid 36384419)
53. Spielman, R. S., McGinnis, R. E., and Ewens, W. J. (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52, 506-516 (Pubitemid 23311321)
54. Delaloye, J., Roger, T., Steiner-Tardivel, Q. G., Le Roy, D., Knaup, R. M., Akira, S., Petrilli, V., Gomez, C. E., Perdiguero, B., Tschopp, J., Pantaleo, G., Esteban, M., and Calandra, T. (2009) Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog. 5, e1000480
55. Lugrin, J., Ding, X. C., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A.-L., Reymond, M. K., Miconnet, I., Schrenzel, J., François, P., and Calandra, T. (2009) Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation. Biochim. Biophys. Acta 1793, 1749-1758
56. Radstake, T. R., Sweep, F. C., Welsing, P., Franke, B., Vermeulen, S. H. H. M., Geurts-Moespot, A., Calandra, T., Donn, R., and Van Riel, P. L. C. M. (2005) Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 52, 3020-3029 (Pubitemid 41447081)
57. Roger, T., Miconnet, I., Schiesser, A. L., Kai, H., Miyake, K., and Calandra, T. (2005) Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression. Biochem. J. 387, 355-365 (Pubitemid 40571221)
58. Donn, R., Alourfi, Z., De Benedetti, F., Meazza, C., Zeggini, E., Lunt, M., Stevens, A., Shelley, E., Lamb, R., Ollier, W. E., Thomson, W., and Ray, D.; British Paediatric Rheumatology Study Group (2002) Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 46, 2402-2409
59. Martin, R. J., Savage, D. A., Carson, D. J., McKnight, A. J., Maxwell, A. P., and Patterson, C. C. (2010) Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with type 1 diabetes mellitus. Diabetes Med. 27, 143-149
60. Haralambous, E., Hibberd, M. L., Hermans, P. W., Ninis, N., Nadel, S., and Levin, M. (2003) Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit. Care Med. 31, 2788-2793 (Pubitemid 38010636)
61. Laird, N. M., and Lange, C. (2006) Family-based designs in the age of large-scale gene-association studies. Nat. Rev. Genet. 7, 385-394
62. Plant, B. J., Gallagher, C. G., Bucala, R., Baugh, J. A., Chappell, S., Morgan, L., O'Connor, C. M., Morgan K., and Donnelly, S. C. (2005) Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am. J. Respir. Crit. Care Med. 172, 1412-1415 (Pubitemid 43069814)
63. Awandare, G. A., Ouma, C., Keller, C. C., Were, T., Otieno, R., Ouma, Y., Davenport, G. C., Hittner, J. B., Ong'echa, J. M., Ferrell, R., and Perkins, D. J. (2006) A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria. Genes Immun. 7, 568-575 (Pubitemid 44614871)
64. Doernberg, S., Schaaf, B., Dalhoff, K., Leng, L., Beitin, A., Quagliarello, V., and Bucala, R. (2011) Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae. Cytokine 53, 292-294
65. Donn, R., Alourfi, Z., Zeggini, E., Lamb, R., Jury, F., Lunt, M., the British Paediatric Rheumatology Study Group, Meazza, C., De Benedetti, F., Thomson, W., and Ray, D. (2004) A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum. 50, 1604-1610 (Pubitemid 38608083)
66. McDevitt, M. A., Xie, J., Shanmugasundaram, G., Griffith, J., Liu, A., McDonald, C., Thuma, P., Gordeuk, V. R., Metz, C. N., Mitchell, R., Keefer, J., David, J., Leng, L., and Bucala, R. (2006) A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J. Exp. Med. 203, 1185-1196 (Pubitemid 43736589)
67. Le Roy, D., Di Padova, F., Adachi, Y., Glauser, M. P., Calandra, T., and Heumann, D. (2001) Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J. Immunol. 167, 2759-2765 (Pubitemid 32768907)
68. Balding, J., Healy, C. M., Livingstone, W. J., White, B., Mynett-Johnson, L., Cafferkey, M., and Smith, O. P. (2003) Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun. 4, 533-540 (Pubitemid 38961148)
69. Endler, G., Marculescu, R., Starkl, P., Binder, A., Geishofer, G., Müller, M., Zöhrer, B., Resch, B., Zenz, W., and Mannhalter, C.; Central European Meningococcal Genetic Study Group (2006) Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia. Clin. Chem. 52, 511-514
70. Lehmann, L. E., Book, M., Hartmann, W., Weber, S. U., Schewe, J. C., Klaschik, S., Hoeft, A., and Stüber, F. (2009) A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study. J. Transl. Med. 7, 100
71. Yende, S., Angus, D. C., Kong, L., Kellum, J. A., Weissfeld, L., Ferrell, R., Finegold, D., Carter, M., Leng, L., Peng, Z.-Y., and Bucala, R. (2009) The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. FASEB J. 23, 2403-2411
72. Gao, L., Flores, C., Fan-Ma, S., Miller, E. J., Moitra, J., Moreno, L., Wadgaonkar, R., Simon, B., Brower, R., Sevransky, J., Tuder, R. M., Maloney, J. P., Moss, M., Shanholtz, C., Yates, C. R., Meduri, G. U., Ye, S. Q., Barnes, K. C., and Garcia, J. G. (2007) Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Transl. Res. 150, 18-29 (Pubitemid 46935595)
73. Kim, K. S. (2003) Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 4, 376-385
74. Koebernick, H., Grode, L., David, J. R., Rohde, W., Rolph, M. S., Mittrücker, H.-W., and Kaufmann, S. H. E. (2002) Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 99, 13681-13686 (Pubitemid 35215441)
75. Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., and Bucala, R. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 99, 345-350 (Pubitemid 34060365)
76. Arjona, A., Foellmer, H. G., Town, T., Leng, L., McDonald, C., Wang, T., Wong, S. J., Montgomery, R. R., Fikrig, E., and Bucala, R. (2007) Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 117, 3059-3066 (Pubitemid 47529635)
77. Amin, M. A., Haas, C. S., Zhu, K., Mansfield, P. J., Kim, M. J., Lackowski, N. P., and Koch, A. E. (2006) Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 107, 2252-2261 (Pubitemid 43345542)
78. Burger-Kentischer, A., Gobel, H., Kleemann, R., Zernecke, A., Bucala, R., Leng, L., Finkelmeier, D., Geiger, G., Schaefer, H. E., Schober, A., Weber, C., Brunner, H., Rütten, H., Ihling, C., and Bernhagen, J. (2006) Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis 184, 28-38 (Pubitemid 41721066)
79. Bondza, P. K., Metz, C. N., and Akoum, A. (2008) Macrophage migration inhibitory factor up-regulates alpha(v) beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa. J. Reprod. Immunol. 77, 142-151 (Pubitemid 351343828)